Velocity Clinical Research

MARCH 19, 2024

Velocity recently convened more than 40 leaders from around the world for a summit on Councils to Accelerate Research Excellence (CARE). The summit focused on Velocity’s Diabetes + Obesity, MASH, Vaccine, Cardiology, and Women’s Health CARE Councils, along with a few areas in development.

Cardiology 52

Cardiology Clinical Trials Clinical Trials Clinical Development 52

Medical Xpress

DECEMBER 16, 2022

Myocardial infarction is an ischemic disease in which a coronary artery supplying blood to the heart muscle is stenotic or obstructed, resulting in cardiac tissue necrosis. Due to the irreversible loss of cardiomyocytes, damaged heart tissue cannot be naturally regenerated.

Development 73

Development Research Cardiology 73

STAT News

JANUARY 6, 2023

… Pfizer told employees it plans to pull back on early-stage research into treatments for rare diseases, including the development of new viral-based gene therapies , Barron’s reports.

Gene Therapy 98

Gene Therapy Trials Research Cardiology 98

Drug Discovery World

AUGUST 7, 2023

Evox Therapeutics has agreed a research collaboration and option agreement with the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) in New York, NY, US. The collaboration will work on developing exosome-encapsulated AAV (exoAAV) vectors as a novel gene delivery technology aimed at improving treatments for heart disease.

Gene Therapy 52

Gene Therapy Gene Research In-Vivo 52

Rethinking Clinical Trials

DECEMBER 20, 2023

Further efforts are urgently needed to increase diversity in the cardiology workforce, which will improve clinical trial diversity and cardiovascular health for all. Approaches from the whole scientific community to tackle the inequality in workforce, trial leadership and trial participants have to be developed.

Clinical Trials 182

Clinical Trials Clinical Trials Trials Cardiology 182

Scienmag

MAY 22, 2022

Madrid, Spain – 22 May 2022: Levels of alcohol consumption currently considered safe by some countries are linked with development of heart failure, according to research presented at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1

Cardiology 77

Cardiology Development Research 77

Medical Xpress

DECEMBER 20, 2022

Using machine learning and clinical data from electronic health records, researchers at the Icahn School of Medicine at Mount Sinai in New York constructed an in silico, or computer-derived, marker for coronary artery disease (CAD) to better measure clinically important characterizations of the disease.

Development 145

Development Medicine Research Cardiology 145

Medical Xpress

FEBRUARY 15, 2023

Traffic noise may play an essential role in the development and deterioration of ischemic heart disease.

Gene Expression 74

Gene Expression Cardiology Gene Research 74

Scienmag

NOVEMBER 13, 2020

Smidt Heart Institute Chair of Cardiology presents new findings at American Heart Association Scientific Sessions Credit: Photo by Cedars-Sinai LOS ANGELES (Nov.

Cardiology 85

Cardiology Development Research Medicine 85

Medical Xpress

MARCH 27, 2023

For the first time, researchers have identified specific regions of the brain that are damaged by high blood pressure and may contribute to a decline in mental processes and the development of dementia.

Research 98

Research Development Cardiology 98

ACRP blog

JANUARY 24, 2023

This expanded clinical research opportunities for patients as a core pillar of the affiliation’s mission, with the goal of providing access to novel treatments for diagnoses in addition to standard of care. An action plan was developed, with steps taken to address clinical research awareness gaps from an institutional perspective.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

Scienmag

MARCH 19, 2022

Sophia Antipolis – 19 March 2022: Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology (ESC).1

Cardiology 61

Cardiology Development Research 61

Medical Xpress

DECEMBER 21, 2022

Identifying early risks and treatments among children and mothers, continued health disparities and finding new ways to use medications already on the market are among some of the significant scientific research developments in the fight against heart disease and stroke that emerged in 2022.

Research 94

Research Marketing Development Cardiology 94

Medical Xpress

JANUARY 4, 2023

In a new study by researchers from Mass General Brigham's founding members, Brigham and Women's Hospital and Massachusetts General Hospital, a team extensively investigated the immune response of 16 adolescents and young adults who developed myocarditis after receipt of the COVID mRNA vaccine.

Immune Response 91

Immune Response Protein Vaccination Vaccine 91

Scienmag

JUNE 17, 2021

Tools for clinicians in point-of-care use UTICA, NY — More than 2 million coronary artery stents are implanted each year to help protect or restore normal blood flow to the heart, to treat patients suffering from angina or a heart attack due to coronary artery disease (CAD). While stents are highly effective and safe devices, […].

Research 72

Research Development Clinical Trials Clinical Trials 72

Scienmag

OCTOBER 18, 2020

Beijing, China 19 Oct 2020: Elevated birth weight is linked with developing atrial fibrillation later in life, according to research presented at the 31st Great Wall International Congress of Cardiology (GW-ICC). Faculty from the European Society of Cardiology (ESC) will participate in joint scientific […].

Cardiology 43

Cardiology Development Research Medicine 43

Velocity Clinical Research

NOVEMBER 21, 2023

“Without clinical research, there would be little if any development of new medicines,” says Isabelle Schenkenberger, MD. I’m proud and excited to be a part of it.” Dr. Schenkenberger is especially proud of her clinical trial research work in heart health, noting most new drugs never make it to market.

Medicine 59

Medicine Cardiology Clinical Research Clinical Trials 59

Drug Discovery World

OCTOBER 19, 2022

Following the news that the number of clinical trial recruiting sites in Ukraine has dropped by half since the Russian invasion, DDW’s Diana Spencer examines clinical trial data from analytics company Phesi and speaks to Dr Olena Karpenko , Clinical Research Director at Medical Center Ok!Clinic+ Rebuilding the Ukrainian research sector.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

The Pharma Data

MARCH 23, 2022

Baynes, head of Global Clinical Development (GCD) and Chief Medical Officer, Merck Research Laboratories (MRL), will be retiring from Merck in July. Li, president, Merck Research Laboratories, until his retirement. He also led the expansion of Merck’s research and development in China and Japan. “It

Clinical Development 52

Clinical Development Development Vaccination Vaccine 52

Scienmag

JUNE 27, 2021

Sophia Antipolis – 28 June 2021: A study in more than 200,000 individuals has found that patients with heart failure are more likely to develop cancer compared to their peers without heart failure.

Cardiology 40

Cardiology Development Research Medicine 40

Rethinking Clinical Trials

FEBRUARY 14, 2024

DCP developed an EHR-based workflows and integrated workflows within the local VA primary care setting. DCP developed 3 electronic workflows with 6 major configurations including applications needed outside of the EHR system. DCP developed a patient tracking tool that nurses could use to make sure patients got through each step.

Clinical Trials 162

Clinical Trials Clinical Trials Cardiology Trials 162

Drug Discovery World

SEPTEMBER 1, 2022

Individuals with an autoimmune disorder have a substantially higher risk of developing cardiovascular disease, a large epidemiological study has revealed. . times depending on which autoimmune condition) of developing cardiovascular disease than people without an autoimmune disorder. . Excess risk comparable to type 2 diabetes.

Cardiology 52

Cardiology Research Development Drugs 52

Scienmag

FEBRUARY 17, 2021

Credit: Mark Bauer/FSU College of Medicine Nearly a half-million people a year die from sudden cardiac death (SCD) in the U.S. — the result of malfunctions in the heart’s electrical system.

Medicine 55

Medicine Genetic Disease Development Genetics 55

Drug Discovery World

FEBRUARY 21, 2023

Researchers have revealed that vaccination against Covid-19 is associated with fewer heart attacks, strokes, and other cardiovascular issues among people who were infected with SARS-CoV-2. Huge dataset Researchers used the National COVID Cohort Collaborative (N3C) database, the largest national comprehensive database on Covid-19.

Vaccination 52

Vaccination Vaccine Cardiology Medicine 52

Scienmag

JULY 22, 2021

New USDA-NIFA funding brings together research, academics, and Extension to improve knowledge, access, and self-monitoring skills for hypertension management Credit: Edwin Remsberg, University of Maryland To address the significant health burden of hypertension (characterized by consistently high blood pressure), the University of Maryland (UMD) was (..)

Development 93

Development Research Cardiology Medicine 93

The Pharma Data

SEPTEMBER 29, 2021

The new FIND-CKD study extends our clinical research for finerenone to a non-diabetic population where the unmet need is high for brand spanking new treatments to delay disease progression.”. Bayer is committed to drive sustainable development and generate a positive impact with its businesses.

Clinical Development 52

Clinical Development Development Clinical Trials Clinical Trials 52

FDA Law Blog

FEBRUARY 21, 2022

Dr. Unger is a cardiologist and former Director of the Office of Drug Evaluation-I in FDA’s Office of New Drugs in the Center for Drug Evaluation and Research (“CDER”). He completed his cardiology training at The Johns Hopkins Hospital in 1987. Unger has joined the firm as a Principal Drug Regulatory Expert.

Drugs 40

Drugs Cardiology FDA Approval Doctors 40

Scienmag

FEBRUARY 1, 2021

— Researchers from Mayo Clinic and AliveCor Inc. have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. This research has yielded a breakthrough in determining the health of the electrical recharging system in a patient’s heart.

Clinical Research 40

Clinical Research Research Development Cardiology 40

Medical Xpress

DECEMBER 7, 2022

Researchers at the University of Southern California Alfred E. Mann Department of Biomedical Engineering have developed a "heart attack on a chip," a device that could one day serve as a testbed to develop new heart drugs and even personalized medicines.

Engineer 105

Engineer Medicine Development Drugs 105

Velocity Clinical Research

JANUARY 3, 2024

The acquisition of KO-MED is Velocity’s first foray into Oncology research, which accounts for roughly 40-50% of clinical trials globally. KO-MED has been the leading multi-site network in Poland since 2020, having enrolled over 9,000 patients into clinical research.

Clinical Trials 52

Clinical Trials Clinical Trials Clinical Research Trials 52

The Pharma Data

JANUARY 12, 2021

12, 2021 (American Heart Association News) — Researchers are soon expected to release initial findings from a national cardiac registry of NCAA athletes who have tested positive for COVID-19 , giving hope to health care professionals trying to better understand the impact of the disease on the heart. TUESDAY, Jan.

Cardiology 52

Cardiology Medicine Doctors Doctor 52

Medical Xpress

MAY 12, 2023

Women who have high blood pressure before they become pregnant may be twice as likely as those who don't to develop cardiovascular disease within a decade of giving birth, new research finds.

Development 98

Development Research Cardiology 98

The Pharma Data

DECEMBER 12, 2020

Chief Executive Officer, Alexion , said: “For nearly 30 years Alexion has worked to develop and deliver transformative medicines to patients around the world with rare and devastating diseases. More recently, AstraZeneca has increased its efforts in immunology research and the development of medicines for immune-mediated diseases.

Development 75

Development Regulation Medicine Containment 75

Medical Xpress

MAY 11, 2023

An algorithm developed using artificial intelligence could soon be used by doctors to diagnose heart attacks with better speed and accuracy than ever before, according to new research from the University of Edinburgh published in Nature Medicine.

Doctors 98

Doctors Doctor Medicine Development 98

Medical Xpress

MAY 17, 2023

With heart disease the most common cause of death worldwide, researchers have attempted to quantify how cumulative exposure to multiple risk factors, like high blood pressure, obesity, and elevated cholesterol, affect an individual's risk of having a heart attack or stroke.

Medicine 101

Medicine Research Development Cardiology 101

pharmaphorum

JUNE 25, 2021

But Dr Craig Granowitz, chief scientific officer of cardiology drug developer Amarin, says that this is only the tip of the iceberg when it comes to the devastating impact of CVD on global populations. “In One of the key takeaways from COVID has been the importance of the endothelial cell – the lining of the blood vessel.

Cardiology 100

Cardiology Drugs Development Licensing 100

Medical Xpress

APRIL 6, 2023

The risk of developing cardiovascular disease is lower in people with obesity who have a genetic predisposition for high BMI than people with obesity influenced mainly by environmental factors such as lifestyle, researchers from Karolinska Institutet report in eClinicalMedicine.

Genetics 98

Genetics Development Research Cardiology 98